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Clinical and preclinical studies have implicated glial anomalies in major depression.
Conversely, evidence suggests that the activity of antidepressant drugs is based, at
least in part, on their ability to stimulate density and/or activity of astrocytes, a major
glial cell population. Despite this recent evidence, little is known about the mechanism(s)
by which astrocytes regulate emotionality. Glial cells communicate with each other
through gap junction channels (GJCs), while they can also directly interact with neurons
by releasing gliotransmitters in the extracellular compartment via an hemichannels
(HCs)-dependent process. Both GJCs and HCs are formed by two main protein
subunits: connexins (Cx) 30 and 43 (Cx30 and Cx43). Here we investigate the role
of hippocampal Cx43 in the regulation of depression-like symptoms using genetic and
pharmacological approaches. The first aim of this study was to evaluate the impact
of the constitutive knock-down of Cx43 on a set of behaviors known to be affected
in depression. Conversely, the expression of Cx43 was assessed in the hippocampus
of mice subjected to prolonged corticosterone (CORT) exposure, given either alone or
in combination with an antidepressant drug, the selective serotonin reuptake inhibitor
fluoxetine. Our results indicate that the constitutive deficiency of Cx43 resulted in the
expression of some characteristic hallmarks of antidepressant-/anxiolytic-like behavioral
activities along with an improvement of cognitive performances. Moreover, in a new
cohort of wild-type mice, we showed that CORT exposure elicited anxiety and
depression-like abnormalities that were reversed by chronic administration of fluoxetine.
Remarkably, CORT also increased hippocampal amounts of phosphorylated form of
Cx43 whereas fluoxetine treatment normalized this parameter. From these results, we
envision that antidepressant drugs may exert their therapeutic activity by decreasing the
expression and/or activity of Cx43 resulting from a lower level of phosphorylation in the
hippocampus.
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INTRODUCTION
Major depression (MD) is one of the most common mental
disorders, aﬀecting 350 million people worldwide and is
a leading cause of disability (Milanovic et al., 2015). MD
imposes substantial economic costs and its impact on disability,
productivity, and quality of life further accentuates these costs
(Lecrubier, 2001). Evidence indicates that stressful life events
increase the risk for MD (Binder and Nemeroﬀ, 2010). As a
consequence, classically used animalmodels of depression rely on
the activation of the hypothalamus-pituitary-adrenal (HPA) axis
in order to reproduce part of the physiological, neurochemical
and morphological maladaptive changes detected in depressed
patients (Dalvi and Lucki, 1999). Selective serotonin reuptake
inhibitors (SSRIs) represent the most widely prescribed class
of antidepressant drugs, but approximately 50% of depressed
patients do not respond adequately to SSRI. Moreover even in
responders, the onset of therapeutic action is of 2–4 weeks (Blier,
2001). Considering the prevalence of MD and its consequences
on life’s quality, a better knowledge of its pathophysiology is
required to envision the identiﬁcation of new therapeutic targets.
Opening the way for a promising area of pharmacological
interventions, recent data suggest that glia plays an important
role in MD and in antidepressant drugs response (Quesseveur
et al., 2013a). Indeed, reduced expression of the glial ﬁbrillary
acidic protein (GFAP) has been observed in the brain of
depressed patients (Miguel-Hidalgo et al., 2000; Webster et al.,
2001; Si et al., 2004; Nagy et al., 2015). This glial anomaly,
speciﬁcally identiﬁed in limbic regions (Torres-Platas et al.,
2015), is not restricted toGFAP since a decrease in cortical mRNA
expression of astrocyte-enriched genes including ALDH1L1,
SOX9, GLUL, SCL1A3 has been reported in a large cohort of
depressed patients (Nagy et al., 2015). In agreement with the
latter ﬁndings, subjecting animals to unpredictable chronic mild
stress (UCMS) or prolonged social defeat, two animal models
of depression, also elicits an attenuation of GFAP (mRNA or
protein) in the cortex (Banasr et al., 2010) or the hippocampus
of rats (Czeh et al., 2006; Araya-Callis et al., 2012). An elevation
in stress-induced glucocorticoids might have contributed to this
eﬀect as studies indicated that corticosterone (CORT) can lower
GFAP levels in the rat brain (Nichols et al., 1990). Despite
this evidence, little is known about the mechanism(s) by which
astrocytic activity may regulate emotionality and its related brain
circuits.
Astrocytes have the ability to communicate with each other
through GJCs, while they can also communicate directly
with neurons by releasing gliotransmitters in the extracellular
compartment via hemichannels (HCs). In astrocytes, both GJCs
and HCs are formed by two main subunits: connexins 30 and
43 (Cx30 and Cx43; Rouach and Giaume, 2001). A few months
ago, a post-mortem study correlated MD with decreased levels
of Cx43 immunoreactivity in the prefrontal cortex (Miguel-
Hidalgo et al., 2014). Similarly, rats subjected to UCMS exhibit
a signiﬁcantly decreased expression and function of cortical and
hippocampal Cx43 GJCs whereas typical antidepressant drugs
such as ﬂuoxetine, duloxetine, or the tricyclic amitriptyline
increased astroglial Cx43 protein levels (Li et al., 2010; Sun et al.,
2012; Morioka et al., 2014; Mostafavi et al., 2014). Although
the latter studies focused their attention on Cx43 without
providing information about Cx30, these clinical and preclinical
observations raise the possibility that the down-regulation and/or
functional inactivation of astroglial Cx GJCs could produce
deleterious eﬀects on mood. Conversely, the over-expression
and/or activation of astroglial Cxs GJCs might underlie, at least
in part, antidepressant drugs response. However, the role of
astroglial Cxs in the regulation of emotional states could be
more complicated than expected. Indeed, it was recently reported
that restraint stress increases the opening of Cx43 HCs in the
hippocampus, thereby promoting the release of glutamate in a
neurotoxic concentration for neighboring cells (Orellana et al.,
2015). Connexin 43 HCs activity may thus constitute a pre-
requisite condition for the damaging eﬀects of chronic stress
on neuronal activity and related functions. Consequently and
given the importance of adult hippocampal neurogenesis in
antidepressant drug response (Santarelli et al., 2001; Surget et al.,
2008; David et al., 2009), the latter results suggest, that the
inactivation of Cx43HCsmight positively inﬂuence emotionality.
Here, we questioned the role of hippocampal Cx43 in the
regulation of emotion-related behaviors using complementary
genetic and pharmacological approaches. In the ﬁrst part of this
study, we evaluated the impact of the constitutive knock-down
of Cx43 on a set of well-deﬁned behavioral paradigms known
to recapitulate several symptoms of depression. The second part
of this work was designed to investigate the putative changes in
hippocampal Cx43 expression in mice chronically exposed to the
stress hormone CORT, either alone or in combination with the
SSRI ﬂuoxetine. The choice of the hippocampus was based on
the fact that this brain region is subjected to intense structural
changes and remodeling in MD while an important part of the
therapeutic activity of antidepressant drugs relies on their ability
to block or reverse impairments of plasticity caused by stress or
related pathologies (Warner-Schmidt and Duman, 2006).
MATERIALS AND METHODS
Animals
For experiment 1, 7 week-old male transgenic Cx43ﬂ/ﬂ mice were
used and wild-type littermates (Cx43wt/wt) with a similar mixed
129P2-C57BL/6 background served as controls (Theis et al.,
2001). For experiments 2 and 3, 7 week-old wild-type C57BL/6J
mice were used. All mice weighed between 25 and 35 g at the
time of behavioral assessment. Mice were housed by 4–5 per cage
under standard conditions (12:12 h light-dark cycle, light on at
7 am, 22 ± 1◦C ambient temperature, 60% relative humidity).
The “Centre de Recherches sur la Cognition Animale (CRCA)”
has received French legal approval for experiments on living
vertebrate animals (Arrêté Préfectoral: 9-02-2011). This work
was carried out in accordance with the Policies of the French
Committee of Ethics. Animal surgery and experimentations
conducted in this study were authorized by the French Direction
of Veterinary Services to CR (#31-11555521, 2002) and all eﬀorts
were made to improve animals’ welfare and minimize animals
suﬀering.
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Drugs and Surgery
Corticosterone (from Sigma–Aldrich, Saint-Quentin Fallavier,
France) was dissolved in vehicle (beta-cyclodextrin 0.45%) as
previously described (David et al., 2009). CORT (35 μg/ml,
equivalent 5 mg/kg/day) was delivered alone or in presence of
the antidepressant drug ﬂuoxetine in opaque bottles to protect it
from light, available ad libitum in the drinking water. Fluoxetine
hydrochloride (18 mg/kg per day for 1 month) was purchased
from Anawa Trading (Wangen, Switzerland) and was used at a
dose that reversed CORT-induced behavioral anomalies (David
et al., 2009). In this study, we also used the non-selective
Cx blocker carbenoxolone (CBX; Rouach et al., 2003) at a
concentration of 10 mM based on a previous report showing its
ability to modulatememory (Bissiere et al., 2011; Sun et al., 2012).
One week before the tests, wild-type mice were anesthetized
with chloral hydrate (400 mg/kg; i.p.). They were then placed
on a stereotaxic frame and bilaterally implanted with 29 gage
guide cannulae (Cooper’s needle works LTD) in the ventral
hippocampus using the following coordinates: −2.5 posterior
from bregma, ±2.8 mm lateral to midline and 2.0 ventral from
the dura. The implants were secured to the skull with dental
acrylic. Dummy cannulae were inserted from the end of surgery
until the infusion day to prevent clogging of the guides. For its
bilateral micro-infusion in the ventral hippocampus (0.3 μl per
side at a constant rate of 0.1 μl/min), CBX was dissolved in
0.1 M sterile PBS. 33 gage internal injection cannulae, extending
0.5 mm beyond the guide cannulae, were inserted and connected
to a microsyringe driven by a microinfusion pump. The cannulae
were left in place for an additional 2 min before being withdrawn
and the animals were allowed an additional 15 min before
the beginning of experimentation. Vehicle animals were also
cannulated and received similar volumes of 0.1 M sterile PBS.
Behavioral Tests
All behavioral tests were performed in the morning to avoid
diﬀerences in locomotor activity and other variables aﬀected by
circadian rhythm. Previous studies have indicated that certain
test variables are sensitive, whereas others are resistant, to test
order (McIlwain et al., 2001). Bearing this in mind, performance
was then evaluated from the least to the most stressful test,
thereby decreasing the chance that one test might impact the
behavior evaluated in the subsequent paradigm. Importantly,
since prior handling and testing have been described to reduce
exploratory activity and emotionality in mice (Võikar et al.,
2004), animals were tested only once in each paradigm. Finally,
given that it has been demonstrated that the interval between
behavioral tests could be as short as 1 day, with a weak eﬀect on
overall performance (Paylor et al., 2006), in the present study,
a 2-day recovery period between tests was provided. It is also
important to state that by reducing the inter-test interval, we
reduced the possible eﬀects of time on drug administration on
tests.
The Sucrose preference test (SPT) was performed in singled-
house mice habituated for 48 h to drink water from two bottles.
On the following 3 days, the mice could choose between a water
bottle and a 1% sucrose solution bottle, switched daily. Sucrose
solution intake for 24 h was measured during the last day and
expressed as a percentage of the total amount of liquid ingested
and normalized to the mouse body weight.
The splash test (ST) was performed for a 5-min period as
previously described (David et al., 2009). After squirting 200 μl
of a 10% sucrose solution on the mouse’s snout, grooming time
was scored by a single experimenter as an index of self-care.
The tail suspension test (TST) was performed using the
BIOSEB’s Tail Suspension Test system (Bioseb) during a 6-
min session period. Immobility time was scored as an index of
resignation. Movements in terms of energy and power in motion
were measured to ensure the absence of any locomotor bias.
The Elevated plus maze (EPM) was performed by placing
animals into the central area facing one closed arm and were
allowed to explore the maze for 5 min. Testing took place in
bright dimmed light conditions (800–900 lux). Automated
scoring was done using ANY-maze(tm) behavioral video-
tracking software from Stoelting Co (Bioseb, Vitrolles, France).
Total number of entries and time spent in the open arms were
measured.
The Open field (OF) was performed in 40 cm × 40 cm
Plexiglas boxes (Mouse Open Field Arena ENV-510; Med
Associates Inc.) during a 30-min session period. Activity
chambers were computer interfaced for data analysis (SOF-811;
Med associates Inc.), and two regions were deﬁned by grid lines
that divided each box into center and periphery areas, with each
of the four lines located 11 cm away from each wall. The total
number of entries, the ambulatory distance and the time spent in
each compartment were measured.
The Novelty suppressed feeding (NSF) was performed in a
white plastic box (30 cm × 60 cm). Mice were food deprived for
24 h before testing and then placed in the corner of the box with
their respective food pellet on a white square ﬁlter paper at the
center of the arena under a bright light (∼60W) placed about 60–
80 cm above the food pellet. Latency to begin eating was scored by
a single experimenter, with a cut-oﬀ time of 10 min. Upon return
to their home-cage, the total amount of food intake was measured
for each animal and for a 5-min period to ensure the absence of
diﬀerences in hunger/motivation to eat.
The Object location test (OLT) and the Object recognition test
(ORT) started with an habituation to the open-ﬁeld by exposing
the mice to the apparatus for 10 min 1 day before starting the
trials (day 1). During the training session, two identical objects
were placed 15 cm away from the two opposite corners (day 2).
Each mouse was placed in the center of the open-ﬁeld, facing the
objects and was allowed to freely explore the objects for 10 min.
During the retention session held 24 h later (day 3), one object
was displaced to a new position (in the OLT), or replaced by
another one (in the ORT). Then, each mouse was placed in the
center of the open-ﬁeld facing the objects and was allowed to
freely move for 10 min. Time spent exploring the diﬀerent objects
was recorded using Noldus Ethovision software.
The Fear conditioning (FC) consisted of a single conditioning
session. During conditioning, each mouse was introduced into
the conditioning chamber for a total of 4 min 30 s. After a
2-min exploration period, a sound (CS) was emitted for 30 s,
and a foot-shock (US) was superposed to the tone during
the last 2 s. The mice were then maintained in the chamber
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for two additional min. After this procedure, the mouse was
gently removed from the chamber. 24 h after the conditioning
session, freezing to the context was assessed by again placing
each mouse in the conditioning chamber. The level of freezing
was measured during 4 min, no tone or foot-shock being
presented to the animal. Two hours later, mice were tested for
freezing to the tone in a modiﬁed context. Two minutes after
introduction in the modiﬁed chamber, freezing was recorded
during a 2-min tone presentation. Freezing behavior was both
automatically recorded and scored by an experimenter blind to
the experimental conditions. Data was calculated for the 4-min
context recall test, the 2-min pre-tone, and the 2-min tone tests.
Emotionality z-Score
Z-normalization across complementary measures of
emotionality-related behaviors assessed from diﬀerent
paradigms was applied after each experimental protocol.
Simple mathematical tools were used to normalize data from
each individual raw behavioral data to the mean of the control
groups within each experimental cohort. Data were then
integrated into a single value, named emotionality z-scores.
Values were obtained by subtracting the average of observations
in a population from an individual raw value and then dividing
this diﬀerence by the population standard deviation as described
previously (Guilloux et al., 2011; Petit et al., 2014). This type of
normalization allows data on diﬀerent scales to be compared.
The emotionality z-score included the parameters measured
in the ST (grooming time), the TST (immobility time), the
elevated plus maze (open arms entries and open arms times),
the open-ﬁeld (center entries, center time, and center to total
distance ratio) and the NSF (latency to feed). It is noteworthy
that several parameters were calculated in the OF and EPM to
evaluate anxiety. In order to have a same impact of each test on
the emotionality z-score, we averaged the normalized parameters
evaluated in the OF and EPM to obtain a single value per mouse
and per behavioral test. More details about the mathematical
method for emotionality z-score calculation are provided in
Supplementary Table S1.
Western-Blot
Expression of Cx30 and Cx43 were analyzed by western blot
as previously described (Ezan et al., 2012). Brieﬂy, frozen
hippocampi or hypothalamus were pulverized on dry ice,
resuspended in boiling 2% SDS containing protease inhibitors
(Roche), β-glycerophosphate (10 mM) and orthovanadate
(1 mM), and sonicated on ice. Lysates were centrifugated at
13,000 rpm at 4◦C and supernatants were diluted with 5x
Laemmli buﬀer, and boiled 5 min. After quantiﬁcation using
the BCA protein assay kit (Pierce), protein samples (20 μg/lane)
were separated by electrophoresis on 10% polyacrylamide gels
(Gel Nupage 4–12%, Bis-Tris) and transferred onto nitrocellulose
membranes. Membranes were blocked for 1 h with 5% fat-
free dried milk/TBS1x-0.1% Tween and incubated overnight at
4◦C either with anti-Cx30 (rabbit polyclonal, Invitrogen 71-
2200, 1/500) or anti-Cx43 (mouse monoclonal, BD Biosciences
610062, 1/500). The next day membranes were washed and
incubated with peroxydase-conjugated goat anti-rabbit or goat
anti-mouse (HRP-IgG, Santa Cruz, respectively, sc-2004 or sc-
2005, 1/2500), for 2 h at room temperature. Chemiluminescent
signal was obtained using Western Lighting Plus ECL detection
kit (Perkin-Elmer NEL104001EA). Blots were reprobed with anti-
tubulin or anti-actin (mouse monoclonal, Sigma, 1/10,000 and
1/30,000; respectively, T6199, A3853) to check protein load.
Semi-quantitative densitometric analysis was performed using
ImageJ software. The analysis of Cx43 activity was assessed
through its level of phosphorylation.
Experimental Design
In the experiment 1 (Supplementary Figure S1A), control
Cx43wt/wt and Cx43ﬂ/ﬂ mice were subjected to a full
comprehensive battery of behavioral tests to evaluate their
phenotype. Separate cohorts were used to assess putative changes
in depressive, anxious and cognitive symptoms.
In the experiment 2 (Supplementary Figure S1B), wild-type
mice were subjected to CORT or its vehicle for 1 month and
then administered with vehicle or ﬂuoxetine for one additional
month. The eﬃcacy of CORT or antidepressants on behavioral
performances were assessed in diﬀerent paradigms. At the end of
this procedure, mice brains were removed for the analysis of Cx43
activity through its level of phosphorylation.
Statistical Analysis
For all experiments, statistical data analysis (StatView 5.0 Abacus
Concepts, Berkeley, CA, USA) used means ± SEM. Student
t-tests and one-way ANOVA followed on treatment factor by
Fisher Protected Least Signiﬁcance Diﬀerence post hoc test were
used. The linear relationship between emotionality z-scores and
the level of expression of non-phosphorylated Cx43 was analyzed
by the Pearson’s correlation coeﬃcient after a Shapiro-Wik
normality test. Signiﬁcant level was set at p< 0.05.
RESULTS
Cx43 Controls Behavioral Symptoms
Related to Depression and Anxiety
Given the distribution of Cx43 in astroglial and stem cells in
the central nervous system (Dermietzel et al., 1989; Kunze et al.,
2009), we proposed to generate mice with a speciﬁc inactivation
of astroglial Cx43 in the hippocampus. To this end, we generated
a pseudotypedMOKOLA lentiviral vectors to selectively drive the
in vivo expression of the Cre-recombinase within hippocampal
astrocytes of Cx43ﬂ/ﬂ mice. The envelope confers to the virus a
tropism toward these glial cells (Colin et al., 2009; Quesseveur
et al., 2013b) and coupling with a detargeting strategy using
miRNA9T and miRNA124T eliminates the putative residual
expression of this Cre-recombinase in hippocampal stem cells
and neurons, respectively, thus providing a selective astrocytic
targeting. However, and as previously shown (Theis et al., 2003;
Unger et al., 2012), we observed that Cx43ﬂ/ﬂ mice themselves
displayed a dramatic decrease in the expression of Cx43 relative
to control Cx43wt/wt mice in various brain regions including
the hippocampus (∼−95%; t1,11 < 0.001) and the hypothalamus
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(∼−85%; t1,6 < 0.05; Figures 1A–D). On this background, the
relevance and the interest of our strategy consisting in over-
expressing the Cre-recombinase within hippocampal astrocytes
was limited. However, we took advantage of the knock-down
of this protein to assess the consequences of constitutive
Cx43 deﬁciency in a set of behavioral aspects known to be
aﬀected in depression: hedonic state, behavioral despair, self-care,
anxiety, and cognition/memory by comparing Cx43ﬂ/ﬂ mice and
Cx43wt/wt mice maintained on the same genetic background.
With respect to hedonic state, no diﬀerences in sucrose
preference was detected between control Cx43wt/wt and Cx43ﬂ/ﬂ
mice (t1,16 = 0.34; Figure 2A) suggesting that the loss of Cx43
did not interfere with mice’s ability to experience pleasure. In the
ST evaluating self-care, no diﬀerence in the time of grooming
was noticed between Cx43wt/wt and Cx43ﬂ/ﬂ mice (t1,16 = 0.8;
Figure 2B). We also assessed immobility during exposure to
inescapable stress using the TST. Cx43ﬂ/ﬂ mice showed a marked
decrease in the immobility time compared to Cx43wt/wt mice,
indicative of a low level of despair (t1,16 < 0.001; Figure 2C).
Mice were then tested in behavioral paradigms assessing
anxiety. In the elevated plus maze, no diﬀerence was observed
between Cx43wt/wt and Cx43ﬂ/ﬂ mice in the time spent in the
open arms (t1,15 = 0.3; Figure 2D) nor in the number of entries
in these arms (t1,15 = 0.4, data not shown). In the OF, which
evaluates locomotor activity in a novel environment as well as
the level of anxiety, an increase, albeit not statistically signiﬁcant,
in the time spent (t1,12 = 0.07; Figure 2E) and the number
of entries in the center area (t1,12 = 0.09; data not shown)
was observed in Cx43ﬂ/ﬂ mice. To eliminate a putative bias, we
FIGURE 1 | Expression of astroglial Cx43 in Cx43fl/fl mice. Immunoblot
analysis (A–C) and quantification (B–D) of Cx43 levels in the hippocampus (B)
and the hypothalamus (D) of Cx43fl/fl mice relative to control Cx43wt/wt mice.
β-actin was used as a loading control. ∗p < 0.05 and ∗∗∗p < 0.001:
significantly different from Cx43wt/wt (n = 6–7 mice/group for the
hippocampus et n = 4 for the hypothalamus).
veriﬁed that the loss of Cx43 did not aﬀect the total distance
traveled (Cx43wt/wt: 8595 ± 575 vs. Cx43ﬂ/ﬂ: 7679 ± 598 cm;
t1,12 = 0.3). In the NSF, which evaluates animal’s latency to
consume food in a novel aversive environment, Cx43ﬂ/ﬂ mice
exhibited a decreased latency to feed compared to Cx43wt/wt
mice (t1,16 < 0.05; Figure 2F and Supplementary Figure S2A
for survival curve). Importantly, body weight loss and food
consumption in the home-cage were similar in both genotypes
(Supplementary Figures S2B,C).
Finally, cognitive/memory functions were assessed by the
measure of performances in the OLT (spatial memory), in the
ORT (non-spatial working memory) and in the fear conditioning
(contextual memory) successively. In the OLT, we found that
Cx43ﬂ/ﬂ mice did not displayed notable spatial memory deﬁcits
compared to control Cx43wt/wt mice. Indeed, during memory
testing 24 h after the acquisition phase, exploratory preference for
mice of both groups were signiﬁcantly higher than chance value
(50%), indicating that animals from both genotypes remembered
the initial position of the objects (Cx43wt/wt mice: p < 0.01 and
Cx43ﬂ/ﬂ mice: p < 0.05; Figure 2G). Moreover, Cx43ﬂ/ﬂ and
control Cx43wt/wt mice similarly explored the displaced object
(t1,15 = 0.1; Figure 2G) indicating that Cx43 know-down had no
eﬀect on spatial memory in this task.
During memory testing in the ORT, Cx43ﬂ/ﬂ and control
Cx43wt/wt mice also explored to the same extent the novel object
(t1,15 = 0.6) and both values were signiﬁcantly diﬀerent from
chance value (Cx43wt/wt mice: p < 0.05 and Cx43ﬂ/ﬂ mice:
p< 0.01; Figure 2H). It is noteworthy that during the acquisition
phase of object location (p= 0.5) and ORT (p= 0.7), both groups
of mice spent the same amount of time exploring the objects
(Supplementary Figures S2D,E). In the fear conditioning,
24 h after the conditioning session, Cx43ﬂ/ﬂ mice exhibited
signiﬁcantly more freezing than Cx43wt/wt mice (t1,15 < 0.01;
Figure 2I). These data are in favor of an improvement of the
associativememory in Cx43ﬂ/ﬂ mice. Interestingly, freezing to the
tone was also studied in a modiﬁed context. As a validation of the
experiment, freezing was measured before the shock on day 1 and
no diﬀerences occurred between Cx43ﬂ/ﬂ and control Cx43wt/wt
mice (t1,15 = 0.12; Supplementary Figure S2F).
These results indicate that the genetic loss of Cx43 elicits
a behavioral phenotype which is similar to that observed in
response to the chronic administration of antidepressant drugs.
Stress and the Selective Serotonin
Reuptake Inhibitor Fluoxetine Display
Opposite Effects on the Functional
Activity of Hippocampal Cx43
Wild-type mice were ﬁrst tested in behavioral paradigms
assessing mood. In the splash and tail suspension tests, the one-
way ANOVA indicated a signiﬁcant eﬀect of treatment factor
[F(2,29) = 21,4; p< 0.001 and F(2,29) = 3,7; p< 0.05; respectively].
In the ST, chronic CORT exposure induced a signiﬁcant decrease
in the time of grooming relative to control mice (p < 0.001)
whereas this depressive-like phenotype was reversed by the
chronic administration of ﬂuoxetine (18 mg/kg/day for 1 month;
p.o.; p < 0.001; Figure 3A). In the TST, although CORT failed
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FIGURE 2 | Behavioral phenotype of Cx43fl/fl mice related to mood, anxiety, and memory. Data are expressed as mean ± SEM. (A–C) Mood evaluated by
the sucrose consumption in the sucrose preference test (SPT; A), the time of grooming in the splash test (ST, B) and the time of immobility in the tail suspension test
(TST; C). (D,E) Anxiety evaluated by the time in the open arms of the elevated plus maze (EPM; D), the time in the center of the open field (OF; E) and the latency to
feed in the novelty suppressed feeding (NSF; F). (G–I) cognitive performances evaluated by the time of exploration of the displaced object in the object location test
(OL; G), of exploration of the novel object in the object recognition test (OR; H) and the time of freezing in the contextual fear conditioning (CFC; I). ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001: significantly different from Cx43wt/wt (n = 8–10 mice/group).
to decrease the time of immobility (p > 0.05), the addition
of ﬂuoxetine signiﬁcantly reduced this parameter pointing its
antidepressant-like activity (p< 0.05; Figure 3B).
With respect to anxiety, in the elevated plus maze, the one-way
ANOVA on the time spent in the open arms revealed a signiﬁcant
eﬀect of treatment factor [F(2,29) = 4,3; p< 0.05]. Indeed, CORT
decreased this parameter (p < 0.05) whereas ﬂuoxetine did not
reverse this eﬀect (p = 0.3; Figure 3C). In the OF, the one-way
ANOVA revealed a signiﬁcant eﬀect of treatment factor on the
time spent in the center but not on the number of entries in
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FIGURE 3 | Behavioral phenotype of wild-type mice subjected to corticosterone (CORT) given alone or in combination with fluoxetine. Data are
expressed as mean ± SEM in wild-type mice administered with with vehicle (VEH) or CORT(35 μg/ml/day; p.o.) given alone or in combination with fluoxetine (FLX;
18 mg/kg/day; p.o.). (A,B) Mood evaluated by the time of grooming in the ST (A) and the time of immobility in the TST (B). (C–E) Anxiety evaluated by the time in the
open arms in the elevated plus maze (EPM; C), the time in the center of the arena in the (D) and the latency to feed in the (E). ∗p < 0.05, ∗∗∗p < 0.001: significantly
different from the VEH-treated group. ###p < 0.001: significantly different from the CORT/VEH-treated group. (n = 10–11 mice/group).
this compartment [F(2,29) = 8,4; p < 0.01 and F(2,29) = 2,1;
p = 0.14; respectively]. Hence, CORT decreased the time in the
center (p < 0.001) and again, ﬂuoxetine failed to signiﬁcantly
reverse this eﬀect (p = 0.3; Figure 3D). Finally, in the NSF, the
one way-ANOVA showed a signiﬁcant eﬀect of treatment factor
[F(2,29) = 14,6; p < 0.001]. CORT induced a signiﬁcant increase
in the latency to feed (p < 0.001) and this eﬀect was reversed
by ﬂuoxetine (p < 0.001; Figure 3E). To eliminate putative
bias, body weight loss and food consumption in the home cage
were monitored and no diﬀerences were observed between the
experimental groups [F(2,29) = 0,1; p = 0.8 and F(2,29) = 0,2;
p = 0.7; respectively] (Supplementary Figures S3A–C).
Because MD is multimodal, quantiﬁable assessment of
depressive-like state is possible when diﬀerent behavioral
parameters can be measured in the same animal. Based on
the z-score method, we thus normalized each parameter from
the average of the corresponding values observed in the
control group and integrated these values into a single score
(Supplementary Table S1). We obtained an emotionality z-score
for which the one-way ANOVA showed a signiﬁcant eﬀect of
treatment factor [F(2,29) = 32,1; p < 0.001]. As expected, CORT
signiﬁcantly increased the emotionality z-score relative to control
animals (p < 0.001) and this eﬀect was reversed by ﬂuoxetine
(p< 0.001; Figure 4A).
In a subgroup of animal subjected to the behavioral paradigms,
we examined their levels of Cx43 expression in the whole
hippocampus. Although one way-ANOVA revealed no eﬀect of
treatment factor on total Cx43 levels [F(2,14) = 0,6; p = 0.5]
(Supplementary Figure S4A), a signiﬁcant eﬀect was reported
on its phosphorylated form [F(2,14) = 5,8; p < 0.05]. We
showed that CORT increased the levels of phosphorylated Cx43
(p < 0.05) and this was reversed by ﬂuoxetine (p < 0.01;
Figure 4B). Interestingly, western blot analysis did not reveal
any eﬀect of treatment factor for the expression of total Cx30
in the hippocampus [F(2,14) = 1,2; p = 0.3] (Supplementary
Figure S4B).
A signiﬁcant positive correlation between emotionality
z-scores and the level of expression of phosphorylated Cx43 was
unveiled (Pearson r = 0.64; p < 0.01; Figure 4C). The higher
the level of phosphorylated Cx43, the higher the emotionality
z-score.
These results demonstrate that the anxiety and depressive-
like symptoms induced by CORT correlate with an increase
in the level of Cx43 phosphorylation in the hippocampus
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FIGURE 4 | Correlation between the phosphorylation state of Connexin
43 and the emotionality-score. (A) emotionality z-score integrating all
behavioral parameters assessed in the ST, test suspension test, elevated plus
maze, OF, and NSF in mice administered with vehicle (VEH) or
CORT(35 μg/ml/day; p.o.) given alone or in combination with fluoxetine (FLX;
18 mg/kg/day; p.o.). Emotionality z-scores used in this correlation analysis
concern the subpopulation of mice for which the expression of hippocampal
Cx43 was examined. (B) Quantification of non-phosphorylated Cx43 levels in
the hippocampus of mice administered with vehicle VEH or CORT given alone
or in combination with FLX. (C) Correlation between emotionality z-scores and
non-phosphorylated Cx43 levels in the hippocampus. Tubulin was used as a
loading control. ∗p < 0.05 and ∗∗∗p < 0.001: significantly different from the
VEH-treated group. ##p < 0.01 and ###p < 0.001: significantly different from
the CORT/VEH-treated group. (n = 10–11 mice/group for z-scores and
n = 5–6 for western-blot).
whereas chronic administration with ﬂuoxetine normalizes this
parameter.
DISCUSSION
In the present study, we provide evidence that the constitutive
knock-down of astroglial Cx43 in mice leads to behavioral
changes reminiscent of antidepressant-/anxiolytic-like activities
speciﬁcally in paradigms producing a high level of stress. In
parallel of these experiments and in a mouse model of depression,
we also report that the antidepressant-/anxiolytic-like activities
of the SSRI ﬂuoxetine is associated with a decrease in the
phosphorylation level of Cx43 in the hippocampus.
To examine the role of Cx43 on emotion-related behaviors,
our initial strategy was to selectively drive the inactivation of
Cx43 within hippocampal astrocytes through a local injection of
pseudotyped lentivirus containing the Cre-recombinase (Colin
et al., 2009). However, the observation that the expression
of Cx43 in Cx43ﬂ/ﬂ mice was dramatically decreased led
us to abandon this strategy and challenge the relevance of
comparing these ﬂoxed mice with their counterparts injected
with the Cre-recombinase in discrete brain regions. Although the
reason of such a constitutive deletion in Cx43ﬂ/ﬂ mice remains
unknown, we decided to compare the behavior of Cx43ﬂ/ﬂ mice
having a constitutive decrease in Cx43 expression as previously
reported (Theis et al., 2003; Unger et al., 2012) with Cx43wt/wt
mice. Our results demonstrate that Cx43ﬂ/ﬂ mice displayed an
antidepressant- and anxiolytic-like phenotype in the TST and
the NSF but not in the ST, the elevated plus maze and the
OF. Hence, we unveiled that the constitutive Cx43 deletion
improves mood and decreases anxiety speciﬁcally in paradigms
producing a high level of stress. Although the role of Cx43 on
these behaviors has been poorly investigated, our results are
in line with earlier experiments showing increased exploratory
and anxiolytic-like behaviors in mice with astrocyte-directed
deletion of Cx43 in the whole brain (i.e., Cx43ﬂ/ﬂ:GFAP-Cremice;
Frisch et al., 2003). We also examined the mnesic performances
of Cx43ﬂ/ﬂ mice because learning and memory impairments
represent other symptoms usually aﬀected in MD as shown in
clinical (Trivedi and Greer, 2014) and preclinical studies (Darcet
et al., 2014). Interestingly, we observed that the constitutive Cx43
deletion improves the long-term memory in the contextual fear
conditioning as antidepressant drugs do (for review see Keefe
et al., 2014). Again, Cx43 deletion produced beneﬁcial eﬀects in
a paradigm for which the intensity of the experienced stress is
high whereas it failed to improve memory in the object location
and ORTs. Together these data shed new light on the fact that
deﬁciency in Cx43 would favor stress response whereas part of
antidepressant activity might rely on the blockade of this protein.
This statement is in line with a recent work showing that Cx43 in
astrocytes may participate in the pathogenesis of stress-associated
psychiatric disorders (Orellana et al., 2015).
To further explore the putative link between stress response
and Cx43, we subjected wild-type mice to CORT and evaluated
the levels of Cx expression. The chronic administration of CORT
in the drinking water is a well-recognized neuroendocrine-
based model of depressive-like behavior (David et al., 2009).
As expected and previously reported in mice (David et al.,
2009; Hache et al., 2012; Quesseveur et al., 2013b; Le Dantec
et al., 2014), we showed that CORT elicited behavioral anomalies
typically observed in depressed patients such as carelessness,
despair, and anxiety. Because full quantiﬁable assessment of
mood-related behavior is possible when the same animal is
exposed to multiple tests covering a wide range of representative
symptoms of depression, we established an emotionality z-score
integrating all these behavioral parameters into a single value.
We provided evidence that CORT signiﬁcantly increased
emotionality z-score compared to control animals as a valid index
of pathological state. Indeed, the higher the emotionality z-score,
the higher the behavioral impairments (Guilloux et al., 2011; Petit
et al., 2014). On the contrary, the sustained administration of
the SSRI decreased this emotionality z-score notably due to its
ability to produce antidepressant-/anxiolytic-like activities in the
ST, TST, and the NSF. Interestingly, neither CORT nor ﬂuoxetine
changed the expression of total Cx43 in the hippocampus but
both treatments aﬀected its levels of phosphorylation. One of
the most remarkable result obtained herein is the fact that
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emotionality z-score is positively correlated with the levels
of Cx43 phosphorylation in the hippocampus. If we consider
that phosphorylation is a prerequisite for acute function of Cx
(Solan and Lampe, 2009), then our results suggest that the
therapeutic eﬀects of antidepressant drugs might implicate the
functional inactivation of Cx43. There is now evidence that
SSRIs inhibit 5-HT uptake through the blockade of neuronal and
astrocytic SERT. The subsequent enhancement of extracellular 5-
HT levels likely contributes to activate astroglial 5-HT receptors
(Quesseveur et al., 2013a) which, in turn, might directly
regulates Cx function and/or expression. In keeping with this
hypothesis, it has been shown that the application of 5-HT on
hippocampal primary culture of astrocytes decreases intracellular
Ca2+ wave propagation or dye transfer between neighboring
cells (Blomstrand et al., 1999). The latter ﬁndings strengthen the
hypothesis that the therapeutic activity of SSRIs would result, at
least in part, from the reduction of glial cells coupling. However,
these considerations are not necessarily consistent with data
showing that chronic treatments with antidepressant drugs such
as ﬂuoxetine or duloxetine increase, on the contrary, astrocytic
Cx43 GJC coupling (Sun et al., 2012) raising the possibility
that the enhancement of astrocyte–astrocyte communication,
notably in the cortex, plays an important role in antidepressant
drugs response. Several explanations might be advanced to
explain the discrepancies between the latter results and the
ﬁndings described in the present study. The brain region (i.e.,
the PFC vs. the hippocampus) is an important concern that
should be taken into consideration. Functional imaging studies
of depressed patients indicate that the clinical response of
ﬂuoxetine is associated with a decreased functional activity of
limbic regions including the hippocampus and an increased
activity of the cortex (Mayberg et al., 2000). It is therefore
possible that cortical and hippocampal astrocytes, according to
their cellular and molecular environment, diﬀerentially impact
neuronal activity. If the activation of Cx43 GJCs in the cortex
seems to exert beneﬁcial antidepressant-like eﬀects, it is possible
that its inactivation in the hippocampus is also a necessary
condition to obtain similar therapeutic responses. To test for
this hypothesis, we directly injected the Cx inhibitor CBX in
the ventral hippocampus. However, our results indicate that the
intra-hippocampal CBX elicited depressive-like state in the TST
(Supplementary Figure S5) similarly to the observation made
after its intra-cortical infusion (Sun et al., 2012). The latter results
strongly suggest that Cx43 GJC and HC exert diﬀerent eﬀects on
stress and antidepressant drugs response.
Opposite Effects of Gap-Junctions and
Hemi-Channels in Response to Stress
and Antidepressant Drugs
On this background, the question may then arise as to whether
the apparent beneﬁcial eﬀects of Cx43 down-regulation and/or
inactivation on antidepressant-/anxiolytic-like activities and
cognitive performances reported herein result from change in
GJC and/or HC activity? The behavioral phenotyping of Cx43-
deﬁcient mice along with pharmacological studies using Cx
blockers in relevant animal models of depression emphasize the
importance of these proteins in the regulation of mood-related
behaviors, while the respective contribution of each function is at
present unknown, in particular for the HC function of Cx43.
Our results unveil a deleterious eﬀect of Cx43 on
antidepressant response. Besides their role in GJC, Cx43
also form HC to allow a direct communication with neurons
by releasing gliotransmitters or other neuroactive substances in
the extracellular compartment (Saez et al., 2005; Ransom and
Giaume, 2013). Interestingly, acute restraint stress stimulates
the opening of astrocytic Cx43 HC and a corollary of such
functional change is an enhancement of glutamate release from
astrocytes HCs thereby leading to neurotoxic eﬀects (Orellana
et al., 2015). These ﬁndings along with the observation that
CRF stimulate the expression of Cx43 (Hanstein et al., 2009),
suggest that enhanced HC activity in astrocytes could contribute
to dysfunction in emotional brain circuits. In our experimental
conditions, one would assume that chronic CORT exposure
stimulated Cx43 HC activity to promote a prolonged and
exaggerated release of glutamate in the hippocampus thereby
producing neuronal damage and/or alteration in mood-related
neurotransmission as previously reported in this model (David
et al., 2009; Rainer et al., 2012). In this case, ﬂuoxetine would
have exerted its beneﬁcial eﬀects by attenuating Cx43 HC activity
reﬂected herein by its ability to decreased Cx43 phosphorylation
in response to stress. In this case, it is, however, unclear why the
majority of gliotransmitters (ATP, adenosine, lactate or D-Serine)
released by Cx43 are known to elicit antidepressant-like eﬀects
(for review Etievant et al., 2013) or to improve fear learning
and memory in rodents (Suzuki et al., 2011; Stehberg et al.,
2012; Yang et al., 2014). One explanation would be that stress
speciﬁcally triggers the release of deleterious gliotransmitters
in a Cx43 HC-dependent manner. Diﬀerent ionic selectivities
for Cx have already been observed (Wang and Veenstra, 1997)
but data on gliotransmitters are still lacking. It is, however,
noteworthy that the degree of Cx43 phosphorylation would be
an important process to regulate such selectivity (Bao et al.,
2007). Finally, we should take into consideration that Cx43
might also allow the secretion of pro-inﬂammatory factors
such as interleukines, cytokines or chemokines. This has been
already observed in response to diﬀerent pathological conditions
including neuropathic pain (Chen et al., 2012, 2014) and this
would reconcile our results with the inﬂammatory hypothesis of
depression.
The second hypothesis regarding Cx43 and emotionality
implies that a normal activity of Cx43-mediated GJC function
is required for antidepressant response. Astroglial GJC are
permeable for several endogenous molecules, i.e., second
messengers [cyclic AMP, inositol-1,4,5-trisphos-phate (InsP3),
and Ca2+], amino acids (glutamate, aspartate, and taurine),
nucleotides (ADP, ATP, CTP, and NAD) but also energy
metabolites and their transfer facilitate information processing
and integration from a large number of neurons, in providing
metabolites during high neuronal demand (Giaume and
Theis, 2010). Considering that antidepressant-like eﬀects of
SSRIs are associated with an enhancement of brain plasticity
(cell proliferation, neuronal growth and sprouting, dendritic
remodeling; Duman et al., 1999), one would expect that the
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facilitation of astrocyte–astrocyte communication would be
in favor of a therapeutic response. As an example of the
physiological importance of communication among these glial
cells, we recently demonstrated that astrocytes are able to release
Brain-Derived Neurotrophic Factor (BDNF) in response to
ﬂuoxetine (Quesseveur et al., 2013b). Given that such a release
can be regulated by the intracellular astrocytic concentration
of Ca2+ (Zafra et al., 1992) or glutamate (Jean et al., 2008)
through Cx43 GJC, we can fairly anticipate their beneﬁcial
eﬀects on antidepressant drug response notably owing to
their proximity with neuronal synapses (Araque et al., 1999;
Perea and Araque, 2010). Indeed, this widespread transfer of
signaling molecules through Cx43 GJC should stimulate brain
plasticity as it represents a neurotrophic supply to neurons.
Interestingly, in a recent study exploring the role of astroglial
Cx on various stages of hippocampal adult neurogenesis, it was
reported that ablation of astroglial Cx43 signiﬁcantly attenuated
proliferation and reduced the survival of adult-born cells (Kunze
et al., 2009; Li et al., 2010; Liebmann et al., 2013) conﬁrming
that these proteins are required to promote hippocampal
adult neurogenesis and related antidepressant-/anxiolytic-like
activities.
CONCLUSION
Although the inﬂuence of antidepressant drugs on Cx43
expression is well described, little is known about the eﬀects
of these treatments on the functional status of Cx43 GJC and
Cx43 HC. Our discussion illustrates the fact that both GJC
and HC may have diﬀerent eﬀects on antidepressant drugs
response leading to a complex regulation of emotionality by
astrocytes. In the present study, we focused our attention
on the hippocampus suggesting that the inactivation of Cx43
HC might induce beneﬁcial eﬀects through an attenuation of
the stress response. The recent identiﬁcation of anatomical
and functional interactions between the hippocampus and
the hypothalamus (Radley and Sawchenko, 2011) reinforces
the interest to further explore the inﬂuence of hippocampal
astroglial Cx43 in the regulation of the neuroendocrine
system.
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FIGURE S1 | Schematic representation of the experimental designs.
(A) Cx43wt/wt and Cx43fl/fl mice were subjected to behavioral tests over a 1-week
period. (B) Wild-type mice were subjected to a 8-week exposure to corticosterone
(CORT) followed by a 4-week exposure to fluoxetine or its vehicle. Behavioral tests
were then conducted for 1 week with a 2-day period between each test.
FIGURE S2 | (A) Survival curve showing the fraction of animal not eating during
the novelty suppressed feeding (NSF). (B) Similar body weight loss (in gr) between
Cx43wt/wt and Cx43fl/fl mice after a 24-h period of fasting. (C) Similar home cage
consumption (in gr/gr of mouse body weight) during 5 min between Cx43wt/wt
and Cx43fl/fl mice after the NSF test. (D,E) Time of exploration of the objects in
the OL (D) and OR (E) during the acquisition phas at D1. (F) Time of freezing
before the shock in the FCF.
FIGURE S3 | (A) Survival curve showing the fraction of animal not eating during
the NSF. (B) Similar body weight loss (in gr) between VEH/VEH-, CORT/VEH-, and
CORT/FLX-treated mice after a 24-h period of fasting. (C) Similar home cage
consumption (in gr/gr of mouse body weight) during 5 min between VEH/VEH-,
CORT/VEH-, and CORT/FLX-treated mice after the NSF test.
FIGURE S4 | Expression of total astroglial Cxs. (A) Levels of Cx43 in
VEH/VEH-, CORT/VEH-, and CORT/FLX-treated mice. (B) Levels of Cx30 in
VEH/VEH-, CORT/VEH-, and CORT/FLX-treated mice.
FIGURE S5 | Depressive-like effect of intra-hippocampal infusion of an
astroglial Cx43 blocker in wild-type mice in the tail suspension test.
(A) Experimental protocol. Wild-type mice were bilaterally implanted with cannula
within the ventral hippocampus and after a 1-week period of recovery, they were
tested in the tail suspension test 15 min after the intra-hippocampal infusion of
carbenoxolone (CBX 10 mM) or its vehicle. The same animals were tested 1 week
later with a higher dose of CBX (100 mM). (A,B) Data are expressed as
mean ± SEM of the time of immobility after CBX (10 mM) (B) or (100 mM) (C).
*p < 0.05: significantly different from the VEH-infused group (n = 7 mice/group).
TABLE S1 | Mathematical method for Emotionality score calculation. The
Z-score is a dimensionless mathematical value obtained by subtracting each
individual data (X) from the mean of the control group (μ) and then dividing the
difference by the standard deviation of the control group (σ). Z-score of the Splash
Test (ST), the Elevated Plus Maze (EPM) and the Open Field (OF) were converted
into opposite values (i.e., by putting the negative sign in front of the formula) in
order to standardize the directionality of these scores and to ensure that increased
values reflected a pathological state. An individual z-score was therefore
determined for each parameter. In the case of behavioral tests integrating multiple
parameters, such as the EPM and the OF, an averaged Z-score was calculated
across parameters. Locomotor activity in the EPM and OF was integrated in the
averaged Z-score of these tests in order to avoid potential biases induced by
locomotion on anxiety-like behaviors. Finally, an individual Emotionality score is
obtained by averaging Z-score of all tests.
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